Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

Most patients were satisfied with topical finasteride, and few experienced side effects.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Finasteride is more harmful to male reproductive health than minoxidil.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Many people in Jordan misuse topical steroids without proper knowledge, highlighting the need for better education and regulation.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Many new moms lose hair after childbirth due to hormonal changes, but it usually grows back within a year.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Hidradenitis suppurativa tunnels worsen the disease and often need surgery because current treatments are not very effective.

These new skin treatments are safer and more effective with minimal side effects.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

SOD1 and KL are promising targets for new hair loss treatments.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Patch testing is crucial to reduce allergic reactions in hair loss treatments.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Valproic acid and isoniazid can interact, causing toxicity, so careful monitoring is needed.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Most emerging dermatological treatments lack strong evidence and require more research.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Nanocarriers can enhance cosmetics but face regulatory and safety challenges.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Linagliptin may cause hair loss and skin blisters.